The role of histologic remission as disease clearance: Emerging treat‐to‐target in pediatric ulcerative colitis

OBJECTIVES: While clinical and endoscopic remission (ER) are established therapeutic targets in ulcerative colitis (UC), endoscopic healing may not fully reflect residual microscopic inflammation. Histologic remission (HR) has been proposed as a deeper marker of disease control and a potential predictor of long-term outcomes. We evaluated whether HR predicts relapses in pediatric UC patients who achieved ER. METHODS: This multicenter retrospective cohort study included pediatric patients with UC (<18 years) who achieved ER (Mayo endoscopic subscore (MES) 0 or 1). HR was defined as a Nancy index score of 0. Patients were stratified into HR and non-HR groups. The primary outcome was clinical relapse, defined as a partial Mayo score ≥3, corticosteroid initiation, requiring treatment escalation, UC-related hospitalization, colectomy or death. Relapse-free survival was analyzed using Kaplan-Meier estimates and Cox proportional hazards models. RESULTS: Among 111 pediatric UC patients with ER, 35 (31.5%) achieved HR. Patients with HR showed significantly improved relapse-free survival than non-HR (log-rank p = 0.015). Multivariable Cox regression demonstrated that both ER (MES 0 vs. 1; hazard ratio 0.57, 95% confidence interval (CI) 0.28-0.94, p = 0.032) and HR (hazard ratio 0.39, 95% CI 0.17-0.91, p = 0.030) independently predicted reduced relapse risk. Notably, even among patients with ER, those with a Nancy index of 0 had superior relapse-free survival versus a score of 1 (p = 0.008). CONCLUSIONS: HR was achieved in only one-third of pediatric patients with UC with ER but was strongly associated with reduced relapse, supporting HR as a treatment target beyond ER.

Authors

Institutions

Publication Details

Journal
Journal of Pediatric Gastroenterology and Nutrition
Published
2026-11-17
DOI
https://doi.org/10.1002/jpn3.70685
Primary Topic
Inflammatory Bowel Disease
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

The role of histologic remission as disease clearance: Emerging treat‐to‐target in pediatric ulcerative colitis

Yiyoung Kwon, Tae Jong Jeong, Yon Ho Choe, Yoon Zi Kim et al.
1 links
Journal of Pediatric Gastroenterology and Nutrition
Inflammatory Bowel Disease
article

The role of histologic remission as disease clearance: Emerging treat‐to‐target in pediatric ulcerative colitis

Yiyoung Kwon, Tae Jong Jeong, Yon Ho Choe, Yoon Zi Kim, Eun Sil Kim, Mi Jin Kim
article en

Abstract

OBJECTIVES: While clinical and endoscopic remission (ER) are established therapeutic targets in ulcerative colitis (UC), endoscopic healing may not fully reflect residual microscopic inflammation. Histologic remission (HR) has been proposed as a deeper marker of disease control and a potential predictor of long-term outcomes. We evaluated whether HR predicts relapses in pediatric UC patients who achieved ER. METHODS: This multicenter retrospective cohort study included pediatric patients with UC (<18 years) who achieved ER (Mayo endoscopic subscore (MES) 0 or 1). HR was defined as a Nancy index score of 0. Patients were stratified into HR and non-HR groups. The primary outcome was clinical relapse, defined as a partial Mayo score ≥3, corticosteroid initiation, requiring treatment escalation, UC-related hospitalization, colectomy or death. Relapse-free survival was analyzed using Kaplan-Meier estimates and Cox proportional hazards models. RESULTS: Among 111 pediatric UC patients with ER, 35 (31.5%) achieved HR. Patients with HR showed significantly improved relapse-free survival than non-HR (log-rank p = 0.015). Multivariable Cox regression demonstrated that both ER (MES 0 vs. 1; hazard ratio 0.57, 95% confidence interval (CI) 0.28-0.94, p = 0.032) and HR (hazard ratio 0.39, 95% CI 0.17-0.91, p = 0.030) independently predicted reduced relapse risk. Notably, even among patients with ER, those with a Nancy index of 0 had superior relapse-free survival versus a score of 1 (p = 0.008). CONCLUSIONS: HR was achieved in only one-third of pediatric patients with UC with ER but was strongly associated with reduced relapse, supporting HR as a treatment target beyond ER.

Journal of Pediatric Gastroenterology and Nutrition
Samsung Medical Center (KR), Kangbuk Samsung Hospital (KR), Sungkyunkwan University (KR)
Samsung
Good health and well-being
Inflammatory Bowel Disease
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon